Managed by NetworkPharma

Managed by

Facilitating Networking and Information Sharing amongst Pharmaceutical and MedComms, Medical Communications, Medical Education and Medical Publishing Specialists

This global initiative facilitates networking and dialogue amongst individuals working in and around the pharmaceutical industry and MedComms, focusing on specialist medical education, medical communications and medical publishing activities.
Why not sign up to our weekly newsletter and please, help spread the word amongst all relevant others.


  • Home
  • About us
  • Testimonials
  • Events
  • Useful Reading
  • In the News
  • Companies
  • Independents
  • Services
  • Special offers
  • Job Adverts
  • Twittering
  • Webcasts
  • Starting out
  • Weekly Newsletter
  • Weekly Comment
  • Survey data
  • Sponsors

  • MedComms Networking on Facebook

    MedComms Networking on Linkedin

    MedComms Networking on Twitter

    MedComms Networking on YouTube

    MedComms Networking is sponsored by:

    Many thanks to all the Sponsors of MedComms Networking


    Every Tuesday we send out the MedComms Networking email newsletter to subscribers. It includes brief commentary on what we're doing and planning, and highlights relevant news to encourage sharing of information, experiences and ideas and to stimulate discussion. The text and links included below, by definition, were accurate on the day of publication, but may then become outdated.

    MedComms Networking - 09 October 2018


    First, thanks to all involved in last week's 4th Virtual MedComms Networking event, Medical Communications for Emerging versus Established Markets. Genevieve Chase of HealthCare21 Singapore set the scene with her presentation and then Sally Stringer, also of HealthCare21 Communications, led a useful panel discussion with Genevieve and the other panel members, Stephen Doyle of ASLAN Pharmaceuticals and Peter West of the Academy of Infection Management. For those who like such detail, we had 187 registrations ahead of time and then peaked at 111 signed in to the actual event. Some of those registrations then represented roomfuls of individuals listening in. So, whilst we don't know for sure, we reckon we were joined by at least 200-250 people from across the globe.

    I'd have been hard-pushed to get those all together in a "real world" room! So many thanks to Blue Sky eLearn for supporting us and to the team at Healthcare21 Communications for helping me with the programme.

    All ideas for more such virtual events are welcomed. Let me know yours.

    But, as I always say, nothing beats meeting in real life, so...

    Next week, on Wednesday 17 October, Oxford PharmaGenesis have invited us in to their central Oxford office to film four talks for under the broad theme of Open Pharma - innovations in medical publishing. It's 2018, the year of the first pharma open access mandate, so ahead of Open Access Week, we'll be exploring how industry can work with other stakeholders to make better use of opportunities for open access, author information systems and preprints to increase speed and transparency within medical publications. Full programme and registration details are here.

    Meanwhile, in case you missed these tidbits last week...

    This press release appeared; GSK updates policy for working with healthcare professionals and, for instance, this is how it was reported by PMLive; GSK to reverse 'no KOLs' policy, admitting it has hit marketing. I didn't hear a whole lot of gasps of surprise. Did you? For reference this was how the then industry-leading policy was reported back in 2013; GlaxoSmithKline to stop paying doctors to promote drugs. It turns out the industry didn't follow...

    The Copyright Clearance Center (CCC) ran a webinar ahead of this week's Frankfurt Book Fair, Get Smart About "Plan S" with Rob Johnson. Useful for everyone, in my opinion (and if you've not heard about "Plan S", catch up! It's important).

    Sticking with open access publishing, read this (free to access) article in The Lancet by Richard Smith; The business of academic publishing: "a catastrophe". Richard reviews a video I've previously recommended; Paywall: The Business of Scholarship. Sadly at 60 minutes most of you will tell me you're too busy. But, if you've the time, it sure makes you think.

    But what do I know? What have you found that's worth sharing?

    Enjoy your week. Remember, details of our activities are kept bang up-to-date at or give me a shout at any time if you've any questions, comments or suggestions.


    Peter Llewellyn
    Managing Director, NetworkPharma Ltd
    Follow me on Twitter @NetworkPharma
    Join 4,000 international colleagues in the MedComms Networking Linkedin Group
    The information at is always bang up-to-date!


    Subscribe to the weekly MedComms Networking email newsletter here - it's entirely free of charge!

    This web site and associated activities are being managed by NetworkPharma Ltd, Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA, UK
    Telephone +44 (0) 1865 784390 Email:

    Our web sites

    [] [] [] []
    [] [] []
    [] [] []